G2B Biologics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth -22.62%
- Profit Growth -3088.71%
- Ebitda 17.01%
- Net Worth -178.48%
- Total Assets -48.82%
About G2B Biologics
G2b Biologics Private Limited (GBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 13 March 2018 (Six years and ten months 28 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sureshkumar Ramasamy and Deepanjan Ghosh serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73200PN2018PTC175351
-
Company No.
175351
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Mar 2018
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at G2B Biologics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepanjan Ghosh
|
Director | 13-Mar-2018 | Current |
|
Sureshkumar Ramasamy
|
Director | 13-Mar-2018 | Current |
Financial Performance of G2B Biologics.
G2B Biologics Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 22.62% decrease. The company also saw a substantial fall in profitability, with a 3088.71% decrease in profit. The company's net worth observed a substantial decline by a decrease of 178.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of G2B Biologics?
In 2021, G2B Biologics had a promoter holding of 99.75% and a public holding of 0.25%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at G2B Biologics?
Unlock and access historical data on people associated with G2B Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of G2B Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped G2B Biologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
